What the Top 10 Biopharma CEOs Are Making

Jul 28 • Biopharmaceutical, Biotechnology • 2127 Views • No Comments on What the Top 10 Biopharma CEOs Are Making

#10. Merck & Co.

Kenneth C. Frazier, Chairman, President, and CEO

2011 Compensation: $13,347,652

2010 Compensation: $9,439,632

% Change: 41.1%

#9. Baxter International

Robert L. Parkinson Jr., Chairman and CEO

2011 Compensation: $14,065,479

2010 Compensation: $11,500,268

% Change: 22.3%

#8. Bristol-Myers Squibb

Lamberto Andreotti, CEO

2011 Compensation: $14,911,947

2010 Compensation: $11,770,880

% Change: 26.7%

#7. Gilead Sciences

John C. Martin, Chairman and CEO

2011 Compensation: $15,615,645

2010 Compensation: $14,244,388

% Change: 9.6%

#6. Novartis

Joseph Jimenez, CEO

2011 Compensation1: $15,881,621

2010 Compensation1: $11,828,828

% Change: 34.3%

#5. Eli Lilly

John C. Lechleiter, Ph.D., Chairman, President, and CEO

2011 Compensation: $16,370,094

2010 Compensation: $16,504,545

% Change: -0.8%

#4. Amgen

Kevin W. Sharer, Chairman and CEO

2011 Compensation: $18,850,311

2010 Compensation: $21,138,133

% Change: -10.8%

#3. Abbott

Miles D. White, Chairman, CEO, and Director

2011 Compensation: $24,010,902

2010 Compensation: $25,564,283

% Change: -6.1%

#2. Pfizer

Ian Read, Chairman and CEO

2011 Compensation: $25,013,348

2010 Compensation: $17,396,112

% Change: 43.8%

#1. Johnson & Johnson

William C. Weldon, Chairman/CEO

2011 Compensation: $26,797,939

2010 Compensation: $28,720,491

% Change: -6.7%

 

 

1

Thanks for installing the Bottom of every post plugin by Corey Salzano. Contact me if you need custom WordPress plugins or website design.

Related Posts

This site uses Akismet to reduce spam. Learn how your comment data is processed.

« »

%d bloggers like this: